1. Division of Cardiology, ASST Bergamo Est, “Bolognini” Hospital, Seriate, Italy; 2. Division of Cardiology, ASST Fatebenefratelli-Sacco, Milan, Italy; 3. Catheterization Laboratory, “Monaldi” Hospital, Naples, Italy; 4. Interventional Cardiology Unit, “
Aims: The aim of this study was to assess outcomes following Absorb bioresorbable scaffold (BVS) implantation in an unrestricted clinical practice according to an “on-label” versus “off-l
Sign in to read and download the full article Forgot your password?
No account yet? Sign up for free! Create my pcr account
Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com
acs/nste-acsbioresorbable scaffoldsmultiple vessel disease
Read next article
Comparison of everolimus-eluting bioresorbable vascular scaffolds and metallic stents: three-year clinical outcomes from the ABSORB China randomised trial